Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00769054Phase 4Completed
Phase 4, randomised, double-blind trial in vaginal prolapse comparing Ropivacaine with Placebo (2 arms). Primary endpoint: Postoperative Pain during rest, coughing and ambulation at 24 hours. Started Oct 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00769054.